Which medications represent a high prevalence (>30%) of adverse reactions, drowsiness, fatigue, or sedation?

While these medications are selective serotonin reuptake inhibitors (SSRIs) commonly prescribed for depression and anxiety, they are generally associated with fewer sedative effects compared to other antidepressants. Adverse reactions such as drowsiness are reported but typically occur in less than 30% of patients, making them less prevalent compared to the correct answer.

Duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), and Bupropion, an atypical antidepressant, are associated with varying side effects. However, neither is primarily known for causing high rates of sedation or drowsiness, with most patients experiencing these effects at lower frequencies than 30%. Escitalopram, part of the SSRI class, follows similar patterns.

Bupropion is known for its stimulating properties and is less likely to cause sedation, while Venlafaxine and Desvenlafaxine, both SNRIs, do not exhibit high levels of sedative effects in most patients. The prevalence of drowsiness or fatigue with these medications is typically below the 30% threshold, making this option incorrect.